Daily propionic acid supplements lowered levels of a nerve damage marker in people with MS, but clinical benefits remain ...

Increasing the Ocrevus dose used in treating MS provided no additional benefit versus the approved regimen in trials with over 1,500 patients.

Living with multiple sclerosis (MS) often means managing a mix of symptoms that affect daily life, including fatigue, mobility challenges, pain, and changes in strength and endurance. Body weight can ...

I was diagnosed with relapsing-remitting multiple sclerosis (RRMS) at the age of 46.

Disease-modifying therapies (DMTs) can help reduce the number and severity of multiple sclerosis (MS) relapses. People who stay on their medication are 42% less likely to relapse than those who don’t ...

Effective management of multiple sclerosis (MS) relies heavily on sustained use of disease-modifying therapies (DMTs) to reduce relapse frequency, slow disability progression and preserve quality of ...